Markets:

Overview

News

Currencies

International

Treasuries

Veralto Corp Common Stock (NY:VLTO)

88.24 +0.04 (+0.05%)

Streaming Delayed Price Updated: 11:45 AM EDT, May 1, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Veralto Corp Common Stock

< Previous 1 2 3 4 5 Next >

Uncovering Noteworthy Technical Analysis Findings for VERALTO CORP (NYSE:VLTO). ↗

October 21, 2024

Interesting Technical Analysis finding for VERALTO CORP (NYSE:VLTO)

Via Chartmill

Peeling Back The Layers: Exploring Veralto Through Analyst Insights ↗

October 16, 2024

Via Benzinga

Price Over Earnings Overview: Veralto ↗

October 04, 2024

Via Benzinga

A Closer Look at 9 Analyst Recommendations For Veralto ↗

September 30, 2024

Via Benzinga

Jim Cramer: Veralto Is A 'Well-Run' Company, Likes This Utilities Stock ↗

September 09, 2024

Cramer is not sure how much higher Veralto can go unless it makes an acquisition or accelerates earnings, and he doesn't see that happening.

Via Benzinga

Forecasting The Future: 9 Analyst Projections For Veralto ↗

August 13, 2024

Via Benzinga

VLTO Stock Earnings: Veralto Beats EPS, Beats Revenue for Q2 2024 ↗

July 25, 2024

VLTO stock results show that Veralto beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.

Via InvestorPlace

Peeling Back The Layers: Exploring Veralto Through Analyst Insights ↗

July 18, 2024

Via Benzinga

6 Analysts Assess Veralto: What You Need To Know ↗

June 14, 2024

Via Benzinga

Forecasting The Future: 7 Analyst Projections For Veralto ↗

April 17, 2024

Via Benzinga

Tap Into Trends: 3 Thematic ETFs to Capture the Market’s Pulse ↗

May 13, 2024

Invest smarter with Wall Street's exchange-traded funds and seize market momentum with these thematic ETFs to buy.

Via InvestorPlace

Topics ETFs

VLTO Stock Earnings: Veralto Beats EPS, Beats Revenue for Q1 2024 ↗

April 23, 2024

VLTO stock results show that Veralto beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.

Via InvestorPlace

Wall Street Favorites: 3 Healthcare Stocks With Strong Buy Ratings for April 2024 ↗

April 11, 2024

Investors wanting to broaden and deepen their portfolio should reach for these healthcare names, each of which is a favorite among analysts.

Via InvestorPlace

Hedge Funds Are Fleeing Tech: 7 Stocks They’re Buying Instead ↗

March 24, 2024

Although tech remains a hot commodity, these stocks hedge funds are buying suggest that a high-level rotation is occurring.

Via InvestorPlace

7 Analysts Assess Veralto: What You Need To Know ↗

March 22, 2024

Via Benzinga

7 Analysts Assess Veralto: What You Need To Know ↗

February 27, 2024

Via Benzinga

Forecasting The Future: 6 Analyst Projections For Veralto ↗

February 08, 2024

Via Benzinga

Earnings Scheduled For February 6, 2024 ↗

February 06, 2024

Companies Reporting Before The Bell • BP (NYSE:BP) is projected to report quarterly earnings at $1.05 per share on revenue of $53.50 billion.

Via Benzinga

Earnings Scheduled For April 23, 2024 ↗

April 23, 2024

Companies Reporting Before The Bell • RTX (NYSE:RTX) is expected to report quarterly earnings at $1.23 per share on revenue of $18.41 billion.

Via Benzinga

A Closer Look at 6 Analyst Recommendations For Veralto ↗

January 09, 2024

Via Benzinga

3 Long-Term Winners from Charles Schwab’s Top Picks ↗

February 27, 2024

Explore the growth and resilience of long-term stocks Microsoft, Merck and Veralto in the latest Charles Schwab stocks portfolio update.

Via InvestorPlace

Danaher's Spun-Off Company Veralto Is "Next High-Quality Serial Compounder" - Analyst ↗

February 27, 2024

Analyst initiates coverage on Veralto Corporation at Outperform rating with $97 price target. Sees strong EPS growth, high-margin businesses, and M&A potential.

Via Benzinga

Health Care Becomes Most Overweighted Sector As Hedge Funds Crowd Into Magnificent 7 ↗

February 21, 2024

Goldman Sachs' Hedge Fund Trend Monitor highlights concentration in mega-caps, with optimism in AI and health care.

Via Benzinga

Topics Artificial Intelligence

2 Buys and 1 Sell From Al Gore's Investment Company ↗

December 14, 2023

An industrial software company, a positioning and workflow company, and a leading life science, bioprocessing, and diagnostics company make up a list of stocks traded by Generation Investment...

Via The Motley Fool

Senator Whitehouse's $3.3M Stock Sale In Pollution Treatment Firm Sparks Insider Trading Suspicions: What Happened? ↗

December 11, 2023

The trades were viewed in a colored light, primarily because Whitehouse is a member of the Senate Committee on Environment.

Via Benzinga

3 Healthcare Stocks to Scoop Up as They Change the Medical Landscape ↗

November 22, 2023

Consider one of these three leading-edge healthcare stocks from companies focused on significant medical innovations.

Via InvestorPlace

3 Water Stocks That Are Betting on the Global H2O Crisis ↗

November 10, 2023

The world faces an increasing water security and quality crisis. These three stocks are set to deliver profitable solutions.

Via InvestorPlace

Danaher's Spun-Off Company Veralto Can Grow Via M&A: Analyst ↗

November 03, 2023

RBC Capital Markets analyst Deane Dray initiated coverage on Veralto Corp (NYSE: VLTO) with a Sector Perform rating and

Via Benzinga

A New Bull Market Is Coming! 3 Stocks Set to Soar 65% to 132% Higher ↗

November 01, 2023

Wall Street has high hopes for these stocks to buy for the next bull market. Consider adding them to your portfolio.

Via InvestorPlace

3 Very Oversold Stocks to Buy In Q4 ↗

October 27, 2023

The market selloff that started in the summer is accelerating, opening up a buy-the-dip opportunity for these oversold stocks.

Via InvestorPlace

< Previous 1 2 3 4 5 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.